<DOC>
	<DOCNO>NCT02280499</DOCNO>
	<brief_summary>Overall study design : This study prospective , multicenter , postmarket clinical observation validate PROMOS™ Standard Shoulder System state-of-the-art implant system total shoulder arthroplasty term radiographic clinical performance well long-term survivorship 10 year .</brief_summary>
	<brief_title>Multicenter Clinical Observation PROMOS®</brief_title>
	<detailed_description>Primary objective : Radiological clinical loosening rate glenoid humeral component must comparable rate well document state-of-the-art shoulder system cement glenoid component . Complications occur intra- postoperatively assessed sub-classified relation implant . At end observation , long-term survival rate calculate accord Kaplan-Meier revision due aseptic loosening end-point . Secondary objective : The Constant Murley score ASES clinical evaluation use document improvement pain , function range motion . For patient 's subjective view improvement function patient self-assessment form use .</detailed_description>
	<criteria>patient general medical contraindication surgery inform consent participate observation sign patient routine radiographic assessment possible patient likely comply study followup requirement primary total hemishoulderarthroplasty affect side , unilateral bilateral acute shoulder trauma tumor / malignoma avascular necrosis late stage rotator cuff disease Charcot joint disease severe neurosensory deficit high comorbidity previously fail shoulder arthroplasty fracture sequela proximal humerus hypersensitivity implant material use addictive disorder alcohol drug abuse severe spinal disorder bacterial infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>